Atika Capital Management LLC Coherus Bio Sciences, Inc. Transaction History

Atika Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $2.81 Million - $3.74 Million	-195,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $155,134 - $203,015	9,500 Added 5.12%	195,000 $3.51 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $399,350 - $572,565	-24,500 Reduced 11.67%	185,500 $3.76 Million
Q2 2019 Aug 12, 2019	BUY	$13.1 - $22.1 $288,200 - $486,200	22,000 Added 11.7%	210,000 $4.64 Million
Q1 2019 May 13, 2019	BUY	$8.38 - $15.5 $1.58 Million - $2.91 Million	188,000 New	188,000 $2.56 Million

148

82.9M

184K

255K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.